Association between the 5-HT6 receptor C267T polymorphism and response to antidepressant treatment in major depressive disorder
- Authors
- Lee, SH; Lee, KJ; Lee, HJ; Ham, BJ; Ryu, SH; Lee, MS
- Issue Date
- Apr-2005
- Publisher
- WILEY
- Keywords
- heterosis; major depressive disorder; polymorphism; serotonin receptor 6 gene; treatment response
- Citation
- PSYCHIATRY AND CLINICAL NEUROSCIENCES, v.59, no.2, pp 140 - 145
- Pages
- 6
- Indexed
- SCIE
SCOPUS
- Journal Title
- PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Volume
- 59
- Number
- 2
- Start Page
- 140
- End Page
- 145
- URI
- https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/19761
- DOI
- 10.1111/j.1440-1819.2005.01348.x
- ISSN
- 1323-1316
1440-1819
- Abstract
- The purpose of the present study was to determine if a 5-HT6 receptor polymorphism is associated with antidepressant treatment response in major depressive disorder (MDD). Ninety-one patients with MDD, compared with 127 normal control subjects, were evaluated after an 8-week treatment period. An association analysis revealed no differences in genotype and allele distribution between patients with MDD and normal control subjects. However, there were significant differences in the treatment response in some Hamilton Depression Rating Scale (HAM-D) scores (sleep, activity, somatic anxiety, and total) between genotypes. Moreover, the heterozygote group (CT genotype) had significantly better treatment response than the homozygote group (CC + TT genotypes), especially in the somatic-anxiety subcategory and the total score of HAM-D. These findings imply that a 5-HT6 receptor polymorphism (C267T) is associated with treatment response in MDD.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 2. Clinical Science > Department of Psychiatry > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.